# A Rollover Study for Patients Who Participated in Other Romidepsin Protocols

> **NCT01353664** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 19 (actual)

## Conditions studied

- Lymphoma
- Cancer

## Interventions

- **DRUG:** Romidepsin

## Key facts

- **NCT ID:** NCT01353664
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-01
- **Primary completion:** 2012-09-05
- **Final completion:** 2012-09-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353664, "A Rollover Study for Patients Who Participated in Other Romidepsin Protocols". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01353664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*